206 related articles for article (PubMed ID: 24759824)
1. Dependence on the CCR5 coreceptor for viral replication explains the lack of rebound of CXCR4-predicted HIV variants in the Berlin patient.
Symons J; Vandekerckhove L; Hütter G; Wensing AM; van Ham PM; Deeks SG; Nijhuis M
Clin Infect Dis; 2014 Aug; 59(4):596-600. PubMed ID: 24759824
[TBL] [Abstract][Full Text] [Related]
2. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
[TBL] [Abstract][Full Text] [Related]
3. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
[TBL] [Abstract][Full Text] [Related]
4. Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.
Wilkin TJ; Goetz MB; Leduc R; Skowron G; Su Z; Chan ES; Heera J; Chapman D; Spritzler J; Reeves JD; Gulick RM; Coakley E
Clin Infect Dis; 2011 Apr; 52(7):925-8. PubMed ID: 21427401
[TBL] [Abstract][Full Text] [Related]
5. Correlation of coreceptor usage and disease progression.
Verhofstede C; Nijhuis M; Vandekerckhove L
Curr Opin HIV AIDS; 2012 Sep; 7(5):432-9. PubMed ID: 22871636
[TBL] [Abstract][Full Text] [Related]
6. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
7. High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.
Nedellec R; Herbeck JT; Hunt PW; Deeks SG; Mullins JI; Anton ED; Reeves JD; Mosier DE
AIDS Res Hum Retroviruses; 2017 Mar; 33(3):234-245. PubMed ID: 27604829
[TBL] [Abstract][Full Text] [Related]
8. Sequential CCR5-Tropic HIV-1 Reactivation from Distinct Cellular Reservoirs following Perturbation of Elite Control.
Watters SA; Mlcochova P; Maldarelli F; Goonetilleke N; Pillay D; Gupta RK
PLoS One; 2016; 11(7):e0158854. PubMed ID: 27403738
[TBL] [Abstract][Full Text] [Related]
9. How HIV changes its tropism: evolution and adaptation?
Mosier DE
Curr Opin HIV AIDS; 2009 Mar; 4(2):125-30. PubMed ID: 19339951
[TBL] [Abstract][Full Text] [Related]
10. Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism.
Kalinina OV; Pfeifer N; Lengauer T
Retrovirology; 2013 Nov; 10():130. PubMed ID: 24215935
[TBL] [Abstract][Full Text] [Related]
11. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants.
Edo-Matas D; van Dort KA; Setiawan LC; Schuitemaker H; Kootstra NA
Virology; 2011 Apr; 412(2):269-77. PubMed ID: 21295814
[TBL] [Abstract][Full Text] [Related]
13. Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.
Cashin K; Roche M; Sterjovski J; Ellett A; Gray LR; Cunningham AL; Ramsland PA; Churchill MJ; Gorry PR
J Virol; 2011 Oct; 85(20):10699-709. PubMed ID: 21835796
[TBL] [Abstract][Full Text] [Related]
14. High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.
Mild M; Gray RR; Kvist A; Lemey P; Goodenow MM; Fenyö EM; Albert J; Salemi M; Esbjörnsson J; Medstrand P
Infect Genet Evol; 2013 Oct; 19():369-77. PubMed ID: 23672855
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.
Xiang SH; Pacheco B; Bowder D; Yuan W; Sodroski J
Virology; 2013 Mar; 438(1):5-13. PubMed ID: 23369572
[TBL] [Abstract][Full Text] [Related]
16. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
Glushakova S; Yi Y; Grivel JC; Singh A; Schols D; De Clercq E; Collman RG; Margolis L
J Clin Invest; 1999 Sep; 104(5):R7-R11. PubMed ID: 10487781
[TBL] [Abstract][Full Text] [Related]
17. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
[TBL] [Abstract][Full Text] [Related]
18. Brief Report: HIV-1 Tropism During Primary Infections in France: 1996-2014.
Raymond S; Nicot F; Sauné K; Cazabat M; Pasquier C; Massip P; Marchou B; Delobel P; Izopet J
J Acquir Immune Defic Syndr; 2016 Aug; 72(4):376-9. PubMed ID: 26959188
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Gupta RK; Abdul-Jawad S; McCoy LE; Mok HP; Peppa D; Salgado M; Martinez-Picado J; Nijhuis M; Wensing AMJ; Lee H; Grant P; Nastouli E; Lambert J; Pace M; Salasc F; Monit C; Innes AJ; Muir L; Waters L; Frater J; Lever AML; Edwards SG; Gabriel IH; Olavarria E
Nature; 2019 Apr; 568(7751):244-248. PubMed ID: 30836379
[TBL] [Abstract][Full Text] [Related]
20. CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.
Sebastian NT; Zaikos TD; Terry V; Taschuk F; McNamara LA; Onafuwa-Nuga A; Yucha R; Signer RAJ; Riddell J; Bixby D; Markowitz N; Morrison SJ; Collins KL
PLoS Pathog; 2017 Jul; 13(7):e1006509. PubMed ID: 28732051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
